Wendt R, Heller M, Hartwig D, Ullmann S, Bisanz H, Geister D
Front Oncol. 2024; 14:1422131.
PMID: 39703837
PMC: 11655464.
DOI: 10.3389/fonc.2024.1422131.
Gandhi A, McCallum J, Fisher J
JCEM Case Rep. 2024; 2(12):luae217.
PMID: 39611185
PMC: 11604075.
DOI: 10.1210/jcemcr/luae217.
Neves A, Mendonca I, Cunha Marques J, Costa J, Almeida J
Cureus. 2023; 15(2):e34770.
PMID: 36909108
PMC: 10001420.
DOI: 10.7759/cureus.34770.
Hocker N, Story M, Lerud A, Kuppachi S
BMJ Case Rep. 2021; 14(6).
PMID: 34187797
PMC: 8245462.
DOI: 10.1136/bcr-2021-242172.
Cox S, Ahalt S, Balhoff J, Bizon C, Fecho K, Kebede Y
JMIR Med Inform. 2020; 8(11):e17964.
PMID: 33226347
PMC: 7721550.
DOI: 10.2196/17964.
Prostate Cancer and Bone Metastases: The Underlying Mechanisms.
Wong S, Mohamad N, Giaze T, Chin K, Mohamed N, Ima-Nirwana S
Int J Mol Sci. 2019; 20(10).
PMID: 31137764
PMC: 6567184.
DOI: 10.3390/ijms20102587.
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing?.
Catalano A, Chila D, Bellone F, Nicocia G, Martino G, Loddo I
J Clin Transl Endocrinol. 2018; 13:9-13.
PMID: 30023309
PMC: 6047106.
DOI: 10.1016/j.jcte.2018.05.004.
Osteoporosis and malignancy: a dicey combination.
Perumal N, Selvi J, Sahoo J, Kamalanathan S
BMJ Case Rep. 2018; 2018.
PMID: 29895544
PMC: 6011445.
DOI: 10.1136/bcr-2017-223881.
An Excess of CYP24A1, Lack of CaSR, and a Novel lncRNA Near the PTH Gene Characterize an Ectopic PTH-Producing Tumor.
Uchida K, Tanaka Y, Ichikawa H, Watanabe M, Mitani S, Morita K
J Endocr Soc. 2017; 1(6):691-711.
PMID: 29264523
PMC: 5686629.
DOI: 10.1210/js.2017-00063.
Primary hyperparathyroidism.
Walker M, Silverberg S
Nat Rev Endocrinol. 2017; 14(2):115-125.
PMID: 28885621
PMC: 6037987.
DOI: 10.1038/nrendo.2017.104.
Hypercalcemia of Malignancy in Thymic Carcinoma: Evolving Mechanisms of Hypercalcemia and Targeted Therapies.
Cheng C, Kuzhively J, Baim S
Case Rep Endocrinol. 2017; 2017:2608392.
PMID: 28168064
PMC: 5266834.
DOI: 10.1155/2017/2608392.
Hypercalcemia of Malignancy and Colorectal Cancer.
Galindo R, Romao I, Valsamis A, Weinerman S, Harris Y
World J Oncol. 2016; 7(1):5-12.
PMID: 26998187
PMC: 4797652.
DOI: 10.14740/wjon953w.
Hypercalcemia of malignancy and new treatment options.
Sternlicht H, Glezerman I
Ther Clin Risk Manag. 2015; 11:1779-88.
PMID: 26675713
PMC: 4675637.
DOI: 10.2147/TCRM.S83681.
Denosumab: a new agent in the management of hypercalcemia of malignancy.
Thosani S, Hu M
Future Oncol. 2015; 11(21):2865-71.
PMID: 26403973
PMC: 4976858.
DOI: 10.2217/fon.15.232.
Unexpected hypercalcemia in a diabetic patient with kidney disease.
Lupica R, Buemi M, Campenni A, Trimboli D, Canale V, Cernaro V
World J Nephrol. 2015; 4(3):438-43.
PMID: 26167468
PMC: 4491935.
DOI: 10.5527/wjn.v4.i3.438.
An unusual case of malignancy-related hypercalcemia.
Doyle M, Malcolm J
Int J Gen Med. 2013; 7:21-7.
PMID: 24353437
PMC: 3862645.
DOI: 10.2147/IJGM.S51302.
Primary hyperparathyroidism: imaging to pathology.
Piciucchi S, Barone D, Gavelli G, Dubini A, Oboldi D, Matteuci F
J Clin Imaging Sci. 2012; 2:59.
PMID: 23230541
PMC: 3515949.
DOI: 10.4103/2156-7514.102053.
Hypercalcemia associated with a malignant brenner tumor arising from a mature cystic teratoma.
Honigberg M, Bradford L, Prabhakar A, Hariri L, Goodman A
Case Rep Oncol. 2012; 5(3):592-600.
PMID: 23185165
PMC: 3506083.
DOI: 10.1159/000345294.
Ectopic secretion of parathyroid hormone in a neuroendocrine tumor: a case report and review of the literature.
Kandil E, Noureldine S, Abdel Khalek M, Daroca P, Friedlander P
Int J Clin Exp Med. 2011; 4(3):234-40.
PMID: 21977238
PMC: 3182517.
Diseases of the parathyroid gland in chronic kidney disease.
Komaba H, Kakuta T, Fukagawa M
Clin Exp Nephrol. 2011; 15(6):797-809.
PMID: 21818548
DOI: 10.1007/s10157-011-0502-5.
